Rbms1-KO Mouse
一般名
Rbms1-KO
製品ID
S-KO-10971
背景情報
C57BL/6JCya
系統ID
KOCMP-56878-Rbms1-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Rbms1-KO Mouse（カタログ番号S-KO-10971）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Rbms1-KO
系統ID
KOCMP-56878-Rbms1-B6J-VA
遺伝子名
製品ID
S-KO-10971
遺伝子別名
YC1, MSSP-1, MSSP-2, MSSP-3, 2600014B10Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 2
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000028347
NCBIトランスクリプトID
NM_020296
ターゲット領域
Exon 3
有効領域の大きさ
~0.1 kb
遺伝子研究の概要
RBMS1, the RNA-binding motif single-strand interacting protein 1, is an important RNA-binding protein. It participates in regulating various biological processes through post-transcriptional regulation, such as influencing mRNA stability and translation [7,8]. It is associated with multiple pathways and is of great biological significance in processes like cell proliferation, apoptosis, and ferroptosis. Genetic models, including gene knockout (KO) or conditional knockout (CKO) mouse models, are valuable tools to study its functions.
In cancer research, RBMS1 shows diverse roles. In lung cancer, RBMS1 depletion inhibits tumor progression both in vivo and in vitro by promoting ferroptosis through inhibiting SLC7A11 translation [1]. In gastric cancer, its overexpression promotes metastasis via the autocrine IL-6/JAK2/STAT3 signaling pathway [2]. In non-small cell lung cancer (NSCLC), RBMS1 interacts with YTHDF1 to promote S100P translation and accelerate metastasis, and its ablation suppresses metastasis [3]. In triple-negative breast cancer, RBMS1 ablation promotes anti-tumor immunity by down-regulating PD-L1 [4]. In ocular melanoma, silencing RBMS1 inhibits cell proliferation and promotes apoptosis [5]. In glioblastoma, interfering with RBMS1 inhibits malignant progression and promotes ferroptosis [6]. In colorectal cancer, inhibiting RBMS1 restores oxaliplatin sensitivity by causing ferroptosis [9]. However, in colon cancer, RBMS1 functions as a suppressor of metastasis through targeted stabilization of its mRNA regulon, and its silencing increases metastatic capacity in xenograft mouse models [8].
In conclusion, RBMS1 is a crucial post-transcriptional regulator involved in multiple biological processes. Studies using KO or CKO mouse models have revealed its significant roles in various cancer-related processes, such as tumor progression, metastasis, ferroptosis, and anti-tumor immunity. Understanding RBMS1's functions provides potential therapeutic targets for treating cancers.
References:
1. Zhang, Wenjing, Sun, Yu, Bai, Lu, Liu, Han, Wang, Yang. . RBMS1 regulates lung cancer ferroptosis through translational control of SLC7A11. In The Journal of clinical investigation, 131, . doi:10.1172/JCI152067. https://pubmed.ncbi.nlm.nih.gov/34609966/
2. Liu, Mengyuan, Li, Heming, Zhang, Huijing, Xue, Lei, Xu, Lu. 2022. RBMS1 promotes gastric cancer metastasis through autocrine IL-6/JAK2/STAT3 signaling. In Cell death & disease, 13, 287. doi:10.1038/s41419-022-04747-3. https://pubmed.ncbi.nlm.nih.gov/35361764/
3. Sun, Yu, Chen, Dan, Sun, Siwen, Wang, Yang, Zhang, Wenjing. 2024. RBMS1 Coordinates with the m6A Reader YTHDF1 to Promote NSCLC Metastasis through Stimulating S100P Translation. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2307122. doi:10.1002/advs.202307122. https://pubmed.ncbi.nlm.nih.gov/38342601/
4. Zhang, Jinrui, Zhang, Ge, Zhang, Wenjing, Liu, Han, Wang, Yang. 2022. Loss of RBMS1 promotes anti-tumor immunity through enabling PD-L1 checkpoint blockade in triple-negative breast cancer. In Cell death and differentiation, 29, 2247-2261. doi:10.1038/s41418-022-01012-0. https://pubmed.ncbi.nlm.nih.gov/35538152/
5. Yang, Ludi, Wang, Gaoming, Tian, Hao, Cui, Ran, Zhuang, Ai. 2024. RBMS1 reflects a distinct microenvironment and promotes tumor progression in ocular melanoma. In Experimental eye research, 246, 109990. doi:10.1016/j.exer.2024.109990. https://pubmed.ncbi.nlm.nih.gov/38969283/
6. Liang, Xiaosong, Wang, Gang, Xue, Chunxiao, Zhou, Yifu. 2024. RBMS1 interference inhibits malignant progression of glioblastoma cells and promotes ferroptosis. In Discover oncology, 15, 548. doi:10.1007/s12672-024-01430-1. https://pubmed.ncbi.nlm.nih.gov/39392522/
7. Shin, Chang Hoon, Rossi, Martina, Anerillas, Carlos, Abdelmohsen, Kotb, Gorospe, Myriam. 2024. Increased ANKRD1 Levels in Early Senescence Mediated by RBMS1-Elicited ANKRD1 mRNA Stabilization. In Molecular and cellular biology, 44, 194-208. doi:10.1080/10985549.2024.2350540. https://pubmed.ncbi.nlm.nih.gov/38769646/
8. Yu, Johnny, Navickas, Albertas, Asgharian, Hosseinali, Mardakheh, Faraz K, Goodarzi, Hani. 2020. RBMS1 Suppresses Colon Cancer Metastasis through Targeted Stabilization of Its mRNA Regulon. In Cancer discovery, 10, 1410-1423. doi:10.1158/2159-8290.CD-19-1375. https://pubmed.ncbi.nlm.nih.gov/32513775/
9. Xu, Yini, Hao, Jingpeng, Chen, Qiang, Zhang, Jingyi, Wang, Hao. 2023. Inhibition of the RBMS1/PRNP axis improves ferroptosis resistance-mediated oxaliplatin chemoresistance in colorectal cancer. In Molecular carcinogenesis, 63, 224-237. doi:10.1002/mc.23647. https://pubmed.ncbi.nlm.nih.gov/37861356/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。